Sun pharma MRs call it a strike on 26th September

Published On 2016-09-12 07:07 GMT   |   Update On 2016-09-12 07:07 GMT
New Delhi : Around 500 Ex-workers of Ranbaxy, who are now working associted with the pharma giant Sun Pharma, have announced for a pan- India strike on september 26, against the non-payment of salaries and issues of Arbitrary Transfers by the company.

Business Standard reports that these Medical representatives have not been paid their salary dues as well as travel expenses for the past three moths. Moreover, there are pending issues regarding the transfer of provident fund for those employees who became a part of Sun Pharma after the giant acquired Ranbaxy. Even after the one year integration process, , the provident fund account is yet to be transferred from the Ranbaxy Charitable Trust, making it difficult for employees to withdraw their PF after leaving the organisation, sources informed the
daily
.

Another issue opposed by the MRs is the arbitrary transfers that have commenced after the integration process for which the MRs have also found support from the Indian Medical Association

“How will a person who knows only Tamil be able to work in Assam without knowing the local language”, IMA asked Dilip Shanghvi, Director Sun Pharma referring to employees’ concerns. Three hundred MRs have already been reported to have resigned from the company because of these transfers

In an e-mail response to this newspaper’s query on employees’ agitation, Sun Pharma said that the harmonisation process has been completed. The company did not wish to comment on the issue of compensation to the employees as the matter is sub judice. The matter will now be heard at the Bombay High Court as Sun Pharma challenged the order of the Labour Court of Maharashtra.

 
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News